Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

It is estimated that around 274,000 people in France suffer from Parkinson’s disease. The vast majority of them follow a ...

Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that sometimes cause impaired decision-making and poor ... Some Diabetes Drugs Tied to ...

The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

While Parkinson’s disease (PD) has a large and highly generalised therapeutic market ... with levodopa therapies and dopamine ...

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease ...

People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...